Cargando…
Deprescribing in Older Adults: Is Evidence for Continued Medication Use Generalizable Beyond Age 75?
Older adults over the age of 75 are severely underrepresented in many of the clinical trials used to justify the continued use of medications for chronic disease prevention in advanced age. The gaps in evidence in this population have fueled an interest in research to better understand the potential...
Autor principal: | Niznik, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7742774/ http://dx.doi.org/10.1093/geroni/igaa057.2912 |
Ejemplares similares
-
Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020) -
Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022) -
Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021) -
A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial
por: Niznik, Joshua, et al.
Publicado: (2022) -
Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)